
Dr Louisa Malcolme-Lawes
Specialized in heart rhythm disturbances. Her NHS practice is based at Imperial College Healthcare NHS Trust and West Herts NHS Trust. She performs all types of catheter ablation and specializes in zero fluoroscopy ablation which is particularly beneficial in young patients or pregnant women wishing to avoid radiation exposure. She also performs all types of device implantation, including conduction system pacemakers and sub-cutaneous ICDs. She has special research interest in atrial fibrillation and the autonomic nervous system, and is undertaking the new technique of cardio neural ablation for vasovagal syncope at Hammersmith Hospital.
.png)
Cardiovascular • Circulatory system • Hypertension • Stress test

SYMPTOMS
Syncope
Syncope, commonly known as fainting, is a temporary loss of consciousness usually caused by a drop in blood flow to the brain. It often occurs suddenly and can be triggered by various factors, including:
.png)
Dehydration
Not having enough fluids in the body can lower blood pressure, leading to fainting.
.png)
Standing up too quickly
This can cause a sudden drop in blood pressure, known as orthostatic hypotension.
.png)
​Emotional stress
Intense emotions such as fear or anxiety can trigger a fainting episode.
.png)
Heart problems:
Conditions like arrhythmias, heart valve disease, or heart failure can affect blood flow and lead to syncope.
Vasovagal response:
This is a common cause of fainting, where the body overreacts to certain triggers like the sight of blood or extreme emotional distress.
.png)
Conditions
Atrial Fibrillation (AF)
Atrial fibrillation is a common heart condition where the heart beats irregularly and often rapidly. This irregular rhythm occurs because the upper chambers of the heart (the atria) beat out of sync with the lower chambers (the ventricles). This can lead to poor blood flow and various symptoms and in a small percentage of patients if left untreated can cause heart failure.

Symptoms
.png)
Palpitations (feeling of a fast, fluttering, or pounding heart)
.png)
Shortness of breath
.png)
Fatigue
.png)
Dizziness or light-headedness
.png)
Chest pain
Causes
AF can be caused by various factors, including:
.png)
High blood pressure
.png)
Heart disease
.png)
Thyroid problems
.png)
Excessive alcohol consumption
.png)
Stress
.png)
Sleep apnoea
Diagnosis
AF is typically diagnosed through an electrocardiogram (ECG), which records the electrical activity of the heart. Other tests may include blood tests, echocardiogram, or a Holter monitor.
Treatment
The treatment for AF aims to control the heart rate, restore a normal rhythm, and reduce the risk of stroke. Treatment options include:
.png)
Medications
.png)
Rate control medications: These help slow down the heart rate.
.png)
Rhythm control medications: These help restore and maintain a normal heart rhythm.
.png)
Anticoagulants: These are blood thinners that reduce the risk of stroke by preventing blood clots.
.png)
Cardioversion
This is a procedure where an electric shock is delivered to the heart to restore a normal rhythm.
.png)
Catheter Ablation
This is a minimally invasive procedure where areas of the heart causing the irregular rhythm are destroyed using radiofrequency energy.
.png)
Lifestyle Changes
-
Reducing alcohol and caffeine intake

-
Managing stress

-
Maintaining a healthy weight

-
Regular physical activity

PROCEDURES
Cardioversion
Cardioversion is a medical procedure used to restore a normal heart rhythm in people with certain types of abnormal heartbeats (arrhythmias). It is often performed when the heart is beating too fast or irregularly, such as in atrial fibrillation or atrial flutter.
THERE ARE TWO MAIN TYPES OF CARDIOVERSION:

Electrical Cardioversion
This involves delivering a controlled electric shock to the heart through paddles or patches placed on the chest. The shock momentarily stops the heart's electrical activity, allowing it to restart in a normal rhythm. This procedure is usually done under sedation to ensure comfort.
.jpg)
Pharmacological Cardioversion
This involves using medications to restore the heart's normal rhythm. These medications can be administered orally or intravenously.
Cardioversion is generally a safe procedure, but like any medical intervention, it carries some risks, including the potential for blood clots, stroke, or other complications. Your doctor will discuss these risks with you and take steps to minimise them, such as prescribing blood thinners if necessary.


The decision to undergo cardioversion will depend on your specific condition, symptoms, and overall health. Your cardiologist will provide detailed information and guidance tailored to your situation.

"Many thanks for the excellent care you and your team gave me during the AT ablation procedure at Hammersmith Hospital last friday. You have a calm and reassuring demeanour, and an impressive collective competence. For that many thanks.”
-Mr RM April 2025
Research & Publications
As an Honorary Clinical Lecturer at Imperial College Dr Malcolme-Lawes continues to be closely involved in ongoing research studies and is Principle Investigator at West Herts NHS Trust for the Protect HF study which is a national study of conduction system pacing being run by Imperial College. She also participates in research activities within Imperial College including student vivas and teaching programs, regularly teaching on the BCS Mayo Clinic Cardiology Board Review Course.
.png)
Catheter Ablation for Vasovagal Syncope: The Therapeutic Potential of Gateway Plexi.
.png)
.png)
Machine learning-derived cycle length variability metrics predict spontaneously terminating ventricular tachycardia in implantable cardioverter defibrillator recipients.
.png)
.png)
Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study.
.png)
.png)
Long-term outcomes of ganglionated plexus ablation as sole therapy for paroxysmal atrial fibrillation.
.png)
.png)
Artificial intelligence-enabled electrocardiogram to distinguish atrioventricular re-entrant tachycardia from atrioventricular nodal re-entrant tachycardia.
.png)
.png)
Postinfarct ventricular tachycardia substrate: Characterization and ablation of conduction channels using ripple mapping.
.png)
.png)
Characterization of conduction system activation in the postinfarct ventricle using ripple mapping.
.png)
.png)
​Feasibility of mapping and ablating ectopy-triggering ganglionated plexus reproducibly in persistent atrial fibrillation.
.png)
.png)
Targeting the ectopy-triggering ganglionated plexuses without pulmonary vein isolation prevents atrial fibrillation.
.png)